These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38812055)

  • 1. A multicenter, matched case-control analysis comparing burden of illness among patients with tuberous sclerosis complex related epilepsy, generalized idiopathic epilepsy, and focal epilepsy in Germany.
    Lappe L; Hertzberg C; Knake S; Knuf M; von Podewils F; Willems LM; Kovac S; Zöllner JP; Sauter M; Kurlemann G; Mayer T; Bertsche A; Marquard K; Meyer S; Schäfer H; Thiels C; Zukunft B; Schubert-Bast S; Reese JP; Rosenow F; Strzelczyk A
    Neurol Res Pract; 2024 May; 6(1):29. PubMed ID: 38812055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicenter, matched case-control analysis comparing burden-of-illness in Dravet syndrome to refractory epilepsy and seizure remission in patients and caregivers in Germany.
    Strzelczyk A; Schubert-Bast S; Bast T; Bettendorf U; Fiedler B; Hamer HM; Herting A; Kalski M; Kay L; Kieslich M; Klein KM; Kluger G; Kurlemann G; Mayer T; Neubauer BA; Polster T; von Spiczak S; Stephani U; Trollmann R; Wiemer-Kruel A; Wolff M; Irwin J; Carroll J; Pritchard C; Rosenow F
    Epilepsia; 2019 Aug; 60(8):1697-1710. PubMed ID: 31247127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct and indirect costs and cost-driving factors in adults with tuberous sclerosis complex: a multicenter cohort study and a review of the literature.
    Zöllner JP; Grau J; Rosenow F; Sauter M; Knuf M; Kurlemann G; Mayer T; Hertzberg C; Bertsche A; Immisch I; Klein KM; Knake S; Marquard K; Meyer S; Noda AH; von Podewils F; Schäfer H; Thiels C; Willems LM; Zukunft B; Schubert-Bast S; Strzelczyk A
    Orphanet J Rare Dis; 2021 Jun; 16(1):250. PubMed ID: 34078440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the burden of idiopathic generalized epilepsy in the United States, Europe, and Brazil: An analysis from the National Health and Wellness Survey.
    Gupta S; Kwan P; Faught E; Tsong W; Forsythe A; Ryvlin P
    Epilepsy Behav; 2016 Feb; 55():146-56. PubMed ID: 26773686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct and indirect costs and cost-driving factors of Tuberous sclerosis complex in children, adolescents, and caregivers: a multicenter cohort study.
    Grau J; Zöllner JP; Schubert-Bast S; Kurlemann G; Hertzberg C; Wiemer-Kruel A; Bast T; Bertsche A; Bettendorf U; Fiedler B; Hahn A; Hartmann H; Hornemann F; Immisch I; Jacobs J; Kieslich M; Klein KM; Klotz KA; Kluger G; Knuf M; Mayer T; Marquard K; Meyer S; Muhle H; Müller-Schlüter K; Noda AH; Ruf S; Sauter M; Schlump JU; Syrbe S; Thiels C; Trollmann R; Wilken B; Willems LM; Rosenow F; Strzelczyk A
    Orphanet J Rare Dis; 2021 Jun; 16(1):282. PubMed ID: 34154622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life and its predictors in adults with tuberous sclerosis complex (TSC): a multicentre cohort study from Germany.
    Zöllner JP; Conradi N; Sauter M; Knuf M; Knake S; Kurlemann G; Mayer T; Hertzberg C; Bertsche A; Immisch I; Klein KM; Marquard K; Meyer S; Noda AH; von Podewils F; Schäfer H; Thiels C; Zukunft B; Schubert-Bast S; Grau J; Willems LM; Rosenow F; Reese JP; Strzelczyk A
    Neurol Res Pract; 2021 Jun; 3(1):35. PubMed ID: 34176514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A quantitative cross-sectional study of the burden of caring for patients with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex-associated epilepsy in Japan.
    LoPresti M; Igarashi A; Sonohara Y; Bowditch S
    Epilepsy Behav; 2024 May; 154():109741. PubMed ID: 38555725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic burden associated with tuberous sclerosis complex in patients with epilepsy.
    Betts KA; Stockl KM; Yin L; Hollenack K; Wang MJ; Yang X
    Epilepsy Behav; 2020 Nov; 112():107494. PubMed ID: 33181900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in resource utilization and cost of illness in patients with active epilepsy in Germany from 2003 to 2020.
    Willems LM; Hochbaum M; Zöllner JP; Schulz J; Menzler K; Langenbruch L; Kovac S; Knake S; von Podewils F; Hamacher M; Hamer HM; Reese JP; Frey K; Rosenow F; Strzelczyk A
    Epilepsia; 2022 Jun; 63(6):1591-1602. PubMed ID: 35305026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burden-of-illness and cost-driving factors in Dravet syndrome patients and carers: A prospective, multicenter study from Germany.
    Strzelczyk A; Kalski M; Bast T; Wiemer-Kruel A; Bettendorf U; Kay L; Kieslich M; Kluger G; Kurlemann G; Mayer T; Neubauer BA; Polster T; Herting A; von Spiczak S; Trollmann R; Wolff M; Irwin J; Carroll J; Macdonald D; Pritchard C; Klein KM; Rosenow F; Schubert-Bast S
    Eur J Paediatr Neurol; 2019 May; 23(3):392-403. PubMed ID: 30871879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology and disease burden of tuberous sclerosis complex in France: A population-based study based on national health insurance data.
    Fagnani F; Laurendeau C; de Zelicourt M; Marshall J
    Epilepsia Open; 2022 Dec; 7(4):633-644. PubMed ID: 36029029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review on the burden of illness in individuals with tuberous sclerosis complex (TSC).
    Zöllner JP; Franz DN; Hertzberg C; Nabbout R; Rosenow F; Sauter M; Schubert-Bast S; Wiemer-Kruel A; Strzelczyk A
    Orphanet J Rare Dis; 2020 Jan; 15(1):23. PubMed ID: 31964424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic burden, work, and school productivity in individuals with tuberous sclerosis and their families.
    Skalicky AM; Rentz AM; Liu Z; Said Q; Nakagawa JA; Frost MD; Wheless JW; Dunn DW
    J Med Econ; 2018 Oct; 21(10):953-959. PubMed ID: 29890870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescription patterns of antiseizure drugs in tuberous sclerosis complex (TSC)-associated epilepsy: a multicenter cohort study from Germany and review of the literature.
    Strzelczyk A; Grau J; Bast T; Bertsche A; Bettendorf U; Hahn A; Hartmann H; Hertzberg C; Hornemann F; Immisch I; Jacobs J; Klotz KA; Kluger G; Knake S; Knuf M; Kurlemann G; Marquard K; Mayer T; Meyer S; Muhle H; Müller-Schlüter K; von Podewils F; Rosenow F; Ruf S; Sauter M; Schäfer H; Schlump JU; Schubert-Bast S; Syrbe S; Thiels C; Trollmann R; Wiemer-Kruel A; Wilken B; Zukunft B; Zöllner JP
    Expert Rev Clin Pharmacol; 2021 Jun; 14(6):749-760. PubMed ID: 33792454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy, Retention and Tolerability of Everolimus in Patients with Tuberous Sclerosis Complex: A Survey-Based Study on Patients' Perspectives.
    Willems LM; Rosenow F; Schubert-Bast S; Kurlemann G; Zöllner JP; Bast T; Bertsche A; Bettendorf U; Ebrahimi-Fakhari D; Grau J; Hahn A; Hartmann H; Hertzberg C; Hornemann F; Immisch I; Jacobs J; Klein KM; Klotz KA; Kluger G; Knake S; Knuf M; Marquard K; Mayer T; Meyer S; Muhle H; Müller-Schlüter K; von Podewils F; Ruf S; Sauter M; Schäfer H; Schlump JU; Syrbe S; Thiels C; Trollmann R; Wiemer-Kruel A; Wilken B; Zukunft B; Strzelczyk A
    CNS Drugs; 2021 Oct; 35(10):1107-1122. PubMed ID: 34275102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epilepsy associated with tuberous sclerosis complex in childhood: Long-term outcome in children after epilepsy surgery and children non-eligible for epilepsy surgery.
    Stomberg M; Bien CG; Kalbhenn T; Polster T; May TW
    Epilepsy Behav; 2021 Sep; 122():108210. PubMed ID: 34311180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the health economic burden of patients with tuberous sclerosis complex (TSC) with epilepsy: a retrospective cohort study in the UK Clinical Practice Research Datalink (CPRD).
    Shepherd C; Koepp M; Myland M; Patel K; Miglio C; Siva V; Gray E; Neary M
    BMJ Open; 2017 Oct; 7(10):e015236. PubMed ID: 28982809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Everolimus in tuberous sclerosis patients with intractable epilepsy: a treatment option?
    Wiegand G; May TW; Ostertag P; Boor R; Stephani U; Franz DN
    Eur J Paediatr Neurol; 2013 Nov; 17(6):631-8. PubMed ID: 23845174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Everolimus treatment of refractory epilepsy in tuberous sclerosis complex.
    Krueger DA; Wilfong AA; Holland-Bouley K; Anderson AE; Agricola K; Tudor C; Mays M; Lopez CM; Kim MO; Franz DN
    Ann Neurol; 2013 Nov; 74(5):679-87. PubMed ID: 23798472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burden of Illness and Quality of Life in Tuberous Sclerosis Complex: Findings From the TOSCA Study.
    Jansen AC; Vanclooster S; de Vries PJ; Fladrowski C; Beaure d'Augères G; Carter T; Belousova E; Benedik MP; Cottin V; Curatolo P; Dahlin M; D'Amato L; Ferreira JC; Feucht M; Hertzberg C; Jozwiak S; Lawson JA; Macaya A; Marques R; Nabbout R; O'Callaghan F; Qin J; Sander V; Sauter M; Shah S; Takahashi Y; Touraine R; Youroukos S; Zonnenberg B; Kingswood JC
    Front Neurol; 2020; 11():904. PubMed ID: 32982929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.